AGT and COVID-19: In severe versus non-severe COVID-19, we observed an overall RAS activation with higher angiotensin I and angiotensin II levels (86 versus 30 pmol/L angiotensin I, p < 0.01; 114 versus 58 pmol/L angiotensin II, p < 0.05; Fig. 2A,B).